AngioDynamics (ANGO) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

AngioDynamics Revenue Highlights

Latest Revenue (Y)

$303.91M

Latest Revenue (Q)

$67.49M

Main Segment (Y)

Med Device

Main Geography (Y)

UNITED STATES

AngioDynamics Revenue by Period

AngioDynamics Revenue by Year

Date	Revenue	Change
2024-05-31	$303.91M	-10.28%
2023-05-31	$338.75M	7.13%
2022-05-31	$316.22M	8.66%
2021-05-31	$291.01M	10.17%
2020-05-31	$264.16M	-26.52%
2019-05-31	$359.48M	4.41%
2018-05-31	$344.29M	-1.53%
2017-05-31	$349.64M	-1.14%
2016-05-31	$353.69M	-0.92%
2015-05-31	$356.97M	0.71%
2014-05-31	$354.45M	3.63%
2013-05-31	$342.03M	54.21%
2012-05-31	$221.79M	2.70%
2011-05-31	$215.96M	-0.04%
2010-05-31	$216.03M	10.76%
2009-05-31	$195.05M	17.15%
2008-05-31	$166.50M	48.36%
2007-05-31	$112.23M	43.05%
2006-06-03	$78.45M	30.12%
2005-05-28	$60.29M	22.90%
2004-05-29	$49.05M	27.63%
2003-05-31	$38.43M	24.42%
2002-05-31	$30.89M	32.06%
2001-05-31	$23.39M	-

AngioDynamics generated $303.91M in revenue during NA 2024, up -10.28% compared to the previous quarter, and up 84.54% compared to the same period a year ago.

AngioDynamics Revenue by Quarter

Date	Revenue	Change
2024-08-31	$67.49M	-4.92%
2024-05-31	$70.98M	-5.59%
2024-02-29	$75.18M	-4.92%
2023-11-30	$79.07M	0.50%
2023-08-31	$78.68M	-13.61%
2023-05-31	$91.07M	12.84%
2023-02-28	$80.71M	-5.52%
2022-11-30	$85.43M	4.77%
2022-08-31	$81.54M	-6.28%
2022-05-31	$87.00M	17.61%
2022-02-28	$73.97M	-5.51%
2021-11-30	$78.28M	1.70%
2021-08-31	$76.97M	0.17%
2021-05-31	$76.84M	7.95%
2021-02-28	$71.18M	-2.18%
2020-11-30	$72.77M	3.64%
2020-08-31	$70.22M	20.37%
2020-05-31	$58.33M	-16.41%
2020-02-29	$69.78M	-0.32%
2019-11-30	$70.00M	6.00%
2019-08-31	$66.04M	-31.42%
2019-05-31	$96.30M	11.53%
2019-02-28	$86.34M	-5.64%
2018-11-30	$91.50M	7.22%
2018-08-31	$85.34M	-3.37%
2018-05-31	$88.32M	5.33%
2018-02-28	$83.85M	-3.29%
2017-11-30	$86.71M	1.52%
2017-08-31	$85.41M	-1.73%
2017-05-31	$86.91M	1.53%
2017-02-28	$85.60M	-3.85%
2016-11-30	$89.03M	1.06%
2016-08-31	$88.10M	-5.65%
2016-05-31	$93.37M	6.85%
2016-02-29	$87.38M	-2.07%
2015-11-30	$89.23M	6.61%
2015-08-31	$83.70M	-7.91%
2015-05-31	$90.90M	4.97%
2015-02-28	$86.60M	-6.03%
2014-11-30	$92.15M	5.52%
2014-08-31	$87.33M	-7.16%
2014-05-31	$94.06M	6.66%
2014-02-28	$88.19M	-0.48%
2013-11-30	$88.62M	6.03%
2013-08-31	$83.58M	-7.17%
2013-05-31	$90.03M	10.37%
2013-02-28	$81.57M	-6.25%
2012-11-30	$87.01M	4.32%
2012-08-31	$83.41M	44.58%
2012-05-31	$57.69M	11.87%
2012-02-29	$51.57M	-11.24%
2011-11-30	$58.10M	6.74%
2011-08-31	$54.43M	-3.19%
2011-05-31	$56.22M	2.88%
2011-02-28	$54.65M	2.39%
2010-11-30	$53.37M	3.62%
2010-08-31	$51.51M	-14.55%
2010-05-31	$60.28M	15.46%
2010-02-28	$52.21M	-2.34%
2009-11-30	$53.46M	6.72%
2009-08-31	$50.09M	-5.16%
2009-05-31	$52.82M	6.82%
2009-02-28	$49.45M	2.03%
2008-11-30	$48.46M	9.34%
2008-08-31	$44.32M	-5.20%
2008-05-31	$46.75M	14.80%
2008-02-29	$40.73M	-

AngioDynamics generated $67.49M in revenue during Q1 2025, up -4.92% compared to the previous quarter, and up 74.11% compared to the same period a year ago.

AngioDynamics Revenue Breakdown

AngioDynamics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	May 24	May 22	May 21	May 20	May 19
Med Device	$197.51M	$237.50M	-	-	-
Med Tech	$106.40M	$78.72M	-	-	-
Endovascular Therapies	-	-	$135.08M	-	-
Oncology Surgery	-	-	$54.62M	$57.15M	-
Access	-	-	-	$94.30M	$94.73M
Peripheral Vascular	-	-	-	$112.71M	-

AngioDynamics's latest annual revenue breakdown by segment (product or service), as of May 24: Med Device (64.99%), and Med Tech (35.01%).

Quarterly Revenue by Product

Product/Service	Aug 24	May 24	Feb 24	Nov 23	Aug 23	May 22	Feb 22	Nov 21	Aug 21
Med Device	$39.52M	$41.64M	$49.34M	$53.71M	$52.82M	$64.40M	$54.36M	$59.39M	$59.35M
Med Tech	$27.97M	$29.34M	$25.84M	$25.36M	$25.86M	$22.60M	$19.61M	$18.89M	$17.62M

AngioDynamics's latest quarterly revenue breakdown by segment (product or service), as of Aug 24: Med Device (58.56%), and Med Tech (41.44%).

AngioDynamics Revenue Breakdown by Country

Annual Revenue by Country

Country	May 24	May 23	May 22	May 21	May 20
International	$52.43M	-	-	-	-
UNITED STATES	$251.49M	$84.33M	$146.88M	$121.43M	$98.97M
Non-US	-	$12.36M	$14.04M	$13.65M	$13.74M

AngioDynamics's latest annual revenue breakdown by geography, as of May 24: UNITED STATES (82.75%), and International (17.25%).

Quarterly Revenue by Country

Country	Aug 24	May 24	Feb 24	Nov 23	Aug 23	May 23	Feb 23	Nov 22	Aug 22	May 22	Feb 22	Nov 21	Aug 21	May 21	Feb 21	Nov 20	Aug 20	May 20	Feb 20	Nov 19
UNITED STATES	$59.48M	$60.74M	$62.34M	$64.00M	$64.40M	$22.96M	$20.38M	$20.55M	$20.44M	$21.87M	$19.48M	$20.70M	$20.48M	$34.23M	$29.53M	$30.69M	$26.98M	$18.90M	$26.79M	$27.60M
Non-US	$8.01M	$12.84M	$15.07M	$14.28M	$3.54M	$2.49M	$3.95M	$2.38M	$4.86M	$3.95M	$4.37M	$4.48M	$3.84M	$3.72M	$3.21M	$2.88M	$3.19M	$3.76M	$3.55M	-

AngioDynamics's latest quarterly revenue breakdown by geography, as of Aug 24: UNITED STATES (88.13%), and Non-US (11.87%).

AngioDynamics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
COO	Cooper Companies	$3.59B	$1.00B
ATR	AptarGroup	$3.49B	$909.29M
NVST	Envista	$2.57B	$884.70M
ICUI	ICU Medical	$2.26B	$589.13M
HAE	Haemonetics	$1.31B	$336.17M
MMSI	Merit Medical Systems	$1.26B	$339.85M
ATRC	AtriCure	$399.25M	$115.91M
ANGO	AngioDynamics	$303.91M	$67.49M
NSTG	NanoString	$127.26M	$48.09M
AKYA	Akoya Biosciences	$96.63M	$18.81M
KRMD	KORU Medical Systems	$28.52M	$8.18M
ATRI	Atrion	-	$48.77M

ANGO Revenue FAQ

What is AngioDynamics’s yearly revenue?

AngioDynamics's yearly revenue for 2024 was $303.91M, representing a decrease of -10.28% compared to 2023. The company's yearly revenue for 2023 was $338.75M, representing an increase of 7.13% compared to 2022. ANGO's yearly revenue for 2022 was $316.22M, representing an increase of 8.66% compared to 2021.

What is AngioDynamics’s quarterly revenue?

AngioDynamics's quarterly revenue for Q1 2025 was $67.49M, a -4.92% decrease from the previous quarter (Q4 2024), and a -14.22% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $70.98M, a -5.59% decrease from the previous quarter (Q3 2024), and a -22.06% decrease year-over-year (Q4 2023). ANGO's quarterly revenue for Q3 2024 was $75.18M, a -4.92% decrease from the previous quarter (Q2 2024), and a -6.85% decrease year-over-year (Q3 2023).

What is AngioDynamics’s revenue growth rate?

AngioDynamics's revenue growth rate for the last 3 years (2022-2024) was -3.89%, and for the last 5 years (2020-2024) was 15.05%.

What are AngioDynamics’s revenue streams?

AngioDynamics's revenue streams in y 24 are Med Device, and Med Tech. Med Device generated $197.51M in revenue, accounting 64.99% of the company's total revenue, down -16.84% year-over-year. Med Tech generated $106.4M in revenue, accounting 35.01% of the company's total revenue, up 35.17% year-over-year.

What is AngioDynamics’s main source of revenue?

For the fiscal year ending May 24, the largest source of revenue of AngioDynamics was Med Device. This segment made a revenue of $197.51M, representing 64.99% of the company's total revenue.